KAZIA THERAPEUTICS LTD (KZIA)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

8.93 on 9 Oct 2026

0 buys0 sales at will0 planned sales

Fiscal year 2025, ended 30 Jun 2025, as filed

Revenue

$42.00K

Net income

$20.70M

Free cash flow

$13.28M

Net margin

-49,290.5%

Revenue growth, 1 yr

-98.2%

Revenue growth, 5 yr

-18.8% a year

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
5 Nov 2013	AUSTIN JOSIAH T 10% owner	Sold, plan not stated	$143.69K	5.8%
4 Nov 2013	AUSTIN JOSIAH T 10% owner	Sold, plan not stated	$153.03K	5.8%
29 Oct 2013	AUSTIN JOSIAH T 10% owner	Sold, plan not stated	$6.64K	0.3%
28 Oct 2013	AUSTIN JOSIAH T 10% owner	Sold, plan not stated	$231.24K	7.9%
25 Oct 2013	AUSTIN JOSIAH T 10% owner	Sold, plan not stated	$386.34K	11.7%
15 Oct 2013	AUSTIN JOSIAH T 10% owner	Sold, plan not stated	$559.21K	14.4%

12out of 100

Profitability 0

Financial strength 9

Growth 0

Insiders 50

Strongest on insiders (50), weakest on growth (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$0.00

0 buys, 0 buyers

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan